Insights into Cannabis-Induced Psychosis and Schizophrenia Progression
Cannabis-induced psychosis schizophrenia progression insights reveal that a significant portion of patients develop schizophrenia spectrum disorders over time. This progression underscores the need for careful clinical monitoring. Understanding these…
Adolescent Cannabis Use & Mental Health Risk: Clinical Evidence
Adolescent cannabis psychotic disorder risk is supported by large population-based studies showing increased psychiatric diagnoses. Cannabis use during adolescence is linked to psychotic, bipolar, depressive, and anxiety disorders. This clinical evidence…
Exploring Posttraumatic Stress, Insomnia, and Cannabis Use
Posttraumatic stress insomnia cannabis use is a critical area of research linking sleep disturbances to substance use risk after trauma. This study highlights the importance of screening for insomnia in trauma survivors. Addressing sleep issues early may…
Clinical Evidence on GLP-1 Receptor Agonists and Mental Health
Glucagon-like peptide-1 receptor agonists mental health effects were studied using genetic methods to assess their impact on psychiatric conditions. Evidence suggests these drugs may influence risk for schizophrenia and substance use disorders.…
Addiction Policy Forum Launches Cannabis Use Disorder Prevention and Awareness Week
Cannabis use disorder prevention strategies are critical as cannabis use rises. The Addiction Policy Forum has launched an awareness week to promote these strategies. Early identification and intervention can reduce the impact of cannabis use disorder.
High-Potency Cannabis Linked to Dramatically Higher Risk of Psychotic Episodes
High-potency THC cannabis risk is strongly associated with increased chances of psychotic episodes. Research highlights that THC concentrations above 10-15% elevate this risk, particularly in adolescents and those with psychiatric history. Understanding…
Medical Use of Cannabis and Adolescent Brain Vulnerability
Adolescent cannabis brain vulnerability is a critical concern due to ongoing neurodevelopment through age 25. Medical cannabis use in teens carries risks for cognition and psychiatric outcomes. Clinicians must apply specific risk-benefit frameworks…
Wake and bake? Ontario may soon let weed stores open at 7 a.m. – Elliot Lake News
Ontario cannabis retail hours are under consideration to shift earlier to 7 a.m. This change may affect consumption timing and daily functioning for users. Clinicians should monitor how these new retail hours impact patient safety and treatment.
Deschutes County Commissioners Advocate for Awareness on Youth Cannabis Risks
Youth cannabis use risks include impaired cognitive development and increased chances of cannabis use disorder. Families play a crucial role in educating teens about these risks. Evidence-based conversations can help prevent early initiation and promote…
An Adapted Brief Negotiation Interview for Alcohol and Cannabis Use Among Assault-Injured Emerging Adults: A Randomized Pilot Trial Protocol
Emerging adults are disproportionately at risk for substance misuse and assault injury. This study focuses on assault-injured emerging adults substance use, adapting a brief negotiation interview. It aims to improve intervention strategies in emergency…